Prashanth Giridhar – författare
Visar alla böcker från författaren Prashanth Giridhar. Handla med fri frakt och snabb leverans.
5 produkter
Evidence based practice in Neuro-oncology
Av Supriya Mallick, Prashanth Giridhar m. fl.
Inbunden, 2021
1690 kr
Lägg i varukorg
This book provides evidence-based management in neuro-oncology covering all aspects such as pathology, radiology, surgery, radiation, and chemotherapy.The field of neuro-oncology is rapidly evolving and new evidence is coming out every day towards the optimal management of brain tumors. This …
Evidence based practice in Neuro-oncology
Av Goura K. Rath, Prashanth Giridhar m. fl.
E-bok, 2021
1670 kr
Lägg i varukorg
This book provides evidence-based management in neuro-oncology covering all aspects such as pathology, radiology, surgery, radiation, and chemotherapy.The field of neuro-oncology is rapidly evolving and new evidence is coming out every day towards the optimal management of brain tumors. This …
Evidence based practice in Neuro-oncology
Av Supriya Mallick, Prashanth Giridhar m. fl.
Häftad, 2022
1241 kr
Lägg i varukorg
This book provides evidence-based management in neuro-oncology covering all aspects such as pathology, radiology, surgery, radiation, and chemotherapy.The field of neuro-oncology is rapidly evolving and new evidence is coming out every day towards the optimal management of brain tumors. This …
Evidence Based Handbook on Diagnosis and Staging in Oncology
Av Satyajit Pradhan, Ashutosh Mukherji m. fl.
Inbunden, 2026
1465 kr
Lägg i varukorg
With the rapid expansion of imaging technologies, molecular markers, and onco‑pathological tests, clinicians increasingly face uncertainty about selecting the most appropriate investigations for diagnosing and staging cancer. This lack of clarity often results in under‑ or over‑investigating, …
Evidence Based Handbook on Diagnosis and Staging in Oncology
Av Prashanth Giridhar, Ashutosh Mukherji m. fl.
E-bok, 2026
1838 kr
Lägg i varukorg
With the rapid expansion of imaging technologies, molecular markers, and onco pathological tests, clinicians increasingly face uncertainty about selecting the most appropriate investigations for diagnosing and staging cancer. This lack of clarity often results in under or over investigating, …